← All companies
TMCI
Treace Medical Concepts, Inc.
$4.68
+0.30 +6.85%
Key statistics
from XBRL data in SEC filingsMarket cap
$304M
Revenue (TTM)
$207M
Net income (TTM)
-$61.0M
EPS (TTM)
$-0.96
P/E ratio
—
Dividend yield
—
Free cash flow
-$29.5M
Cash
$9.54M
Total assets
$184M
Gross margin
79.7%
52-week range
$1.17 – $7.78
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Shareholder vote results
May 20, 2026
10-Q
Quarter ended 2026-03-31
May 8, 2026
8-K
Results of operations (earnings release)
May 8, 2026
8-K
Results of operations (earnings release); Director or officer change; Regulation FD disclosure
Apr 9, 2026
10-K
Fiscal year ended 2025-12-31
Feb 27, 2026
8-K
Results of operations (earnings release)
Feb 27, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Jan 13, 2026
8-K
Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Modified rights of security holders; Regulation FD disclosure; Other events
Dec 18, 2025
10-Q
Quarter ended 2025-09-30
Nov 6, 2025
8-K
Results of operations (earnings release); Director or officer change
Nov 6, 2025
10-Q
Quarter ended 2025-06-30
Aug 7, 2025
8-K
Results of operations (earnings release)
Aug 7, 2025
8-K
Shareholder vote results
May 21, 2025
10-Q
Quarter ended 2025-03-31
May 8, 2025
8-K
Results of operations (earnings release)
May 8, 2025
8-K
Director or officer change
Apr 7, 2025
10-K
Fiscal year ended 2024-12-31
Feb 27, 2025
8-K
Results of operations (earnings release)
Feb 27, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Jan 13, 2025
10-Q
Quarter ended 2024-09-30
Nov 5, 2024
8-K
Results of operations (earnings release)
Nov 5, 2024
8-K
Regulation FD disclosure
Oct 15, 2024
10-Q
Quarter ended 2024-06-30
Aug 6, 2024
8-K
Results of operations (earnings release)
Aug 6, 2024
8-K
Shareholder vote results
May 22, 2024
10-Q
Quarter ended 2024-03-31
May 7, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
May 7, 2024
10-K
Fiscal year ended 2023-12-31
Feb 27, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 27, 2024
8-K
Regulation FD disclosure
Jan 10, 2024
8-K
Results of operations (earnings release)
Jan 8, 2024
10-Q
Quarter ended 2023-09-30
Nov 9, 2023
8-K
Results of operations (earnings release)
Nov 9, 2023
10-Q
Quarter ended 2023-06-30
Aug 9, 2023
8-K
Results of operations (earnings release)
Aug 8, 2023
8-K
Completed an acquisition or disposition
Jun 13, 2023
8-K
Regulation FD disclosure; Other events
Jun 1, 2023
8-K
Shareholder vote results
May 26, 2023
10-Q
Quarter ended 2023-03-31
May 9, 2023
8-K
Results of operations (earnings release)
May 8, 2023